Background
==========

Increased cancer risk has been well established in several HIV-infected populations. However, studies investigating mortality after a diagnosis of cancer have been limited in size, scope, and HIV-specific risk factors.

Materials and methods
=====================

CNICS is a cohort of over 20,000 HIV-infected adults in clinical care at eight U.S. sites. We included patients with chart review verified incident cancer diagnoses between 1996 and 2009. Non-AIDS defining cancers (NADC) were categorized as infection (HPV, EBV, or HBV/HCV)-related \[1\]: squamous cell anal, squamous cell oral cavity/pharynx, penis, vagina/vulva, Hodgkins, and liver; or non-infection-related: all other NADCs. Death was confirmed by the National Death Index and/or state death certificate data. We examined independent predictors of mortality by employing Cox proportional hazards regression models.

Results
=======

918 adults with HIV and cancer were included in this analysis. 55% had AIDS-defining cancer (ADC), 15% had infection-related NADC, and 30% had non-infection related NADC. At cancer diagnosis, median age was 43 years, 50% were white, 86% male, 19% IDU, 21% HBV/HCV, 46% current smokers, and 56% current alcohol drinkers. Median CD4+ cell count was 192 cells/mm^3^ and HIV RNA was 3.6 log~10~ copies/ml. There were 395 deaths in 2,393 person-years of follow-up for a crude mortality rate of 16.5 per 100 person-years (95% CL: 15.0, 18.2). Adjusted hazard of mortality was significantly increased among individuals who were older, non-white, IDU, current or former smokers, had lower CD4+ cell count, higher HIV RNA, and non-infection related NADC (see Table [1](#T1){ref-type="table"}). Figure [1](#F1){ref-type="fig"} shows cumulative mortality after cancer diagnosis stratified by type of cancer.

                                   Mortality Hazard Ratio\*   95% Confidence Limits
  -------------------------------- -------------------------- -----------------------
  Age, per 10 years                1.23                       1.09, 1.40
  White                            0.77                       0.62, 0.95
  Male                             1.06                       0.78, 1.44
  HBV/HCV                          1.11                       0.86, 1.43
  IDU                              1.31                       1.00, 1.70
  Smoking:                                                    
    Never                          1                          \-
    Former                         1.51                       1.08, 2.12
    Current                        1.45                       1.04, 2.02
  Alcohol intake:                                             
    Never                          1                          \-
    Former                         0.99                       0.72, 1.36
    Current                        0.78                       0.58,1.04
  HIV RNA, per log~10~ copies/ml   1.09                       1.01, 1.17
  CD4 count:                                                  
    \> 500 cells/mm^3^             1                          \-
    200--500 cells/mm^3^           1.11                       0.77, 1.59
    \< 200 cells/mm^3^             1.57                       1.10, 2.26
  Summary cancer type:                                        
    ADC                            1                          \-
    Infection-related NADC         0.78                       0.55, 1.11
    Non-infection-related NADC     1.38                       1.05, 1.82

\*Adjusted for all variables in the table.

![**Mortality after cancer diagnosis for 918 HIV+ adults by cancer type.** Non-infection-related NADC is solid line, ADC is dotted line, and infection-related NADC is dashed line.](1750-9378-5-S1-A56-1){#F1}

Conclusions
===========

In the era of ART, unique independent predictors of mortality among individuals with HIV and cancer were level of immune suppression, degree of HIV RNA replication, and non-infection-related type of cancer. These data highlight the need to improve prevention and management of NADC in this population.
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